MiNK Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 02/11/2025 | 234,182 | $163,225 | 0.00% | 0.59% |
LONGBOW FINANCE SA | 02/04/2025 | 166,666 | $116,150 | 0.00% | 0.42% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 101,707 | $70,879 | -4.67% | 0.26% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 96,113 | $66,998 | -1.91% | 0.24% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 88,281 | $61,523 | 0.18% | 0.22% |
HIGHTOWER ADVISORS, LLC | 02/07/2025 | 50,676 | $35,316 | -2.03% | 0.13% |
STATE STREET CORP | 02/14/2025 | 25,515 | $17,781 | 0.00% | 0.06% |
GREENWICH WEALTH MANAGEMENT LLC | 02/10/2025 | 10,805 | $8,000 | 0.00% | 0.03% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 10,079 | $7,024 | -4.31% | 0.03% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 5,401 | $3,764 | 34.12% | 0.01% |
UBS GROUP AG | 02/14/2025 | 2,847 | $1,984 | -54.17% | 0.01% |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1,431 | $1,008 | 0.00% | 0.00% |
COVESTOR LTD | 02/13/2025 | 1,049 | $1,000 | 0.00% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 325 | $227 | 151.94% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 247 | $172 | 100.00% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 190 | $132 | 0.00% | 0.00% |
GAME PLAN FINANCIAL ADVISORS, LLC | 01/30/2025 | 170 | $116 | 0.00% | 0.00% |
KEY FINANCIAL INC | 01/31/2025 | 43 | $30 | 0.00% | 0.00% |
ALLWORTH FINANCIAL LP | 01/30/2025 | 2 | $3 | 0.00% | 0.00% |
FMR LLC | 02/13/2025 | 1 | $1 | 100.00% | 0.00% |
CLEARSTEAD ADVISORS, LLC | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
CHILTON CAPITAL MANAGEMENT LLC | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
JAFFETILCHIN INVESTMENT PARTNERS, LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
MiNK Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 32 institutional investors and hedge funds held shares of MiNK Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 234,182
Longbow Finance SA: 166,666
RENAISSANCE TECHNOLOGIES LLC: 101,707
GEODE CAPITAL MANAGEMENT, LLC: 96,113
BlackRock Funding, Inc. /DE: 88,281
HighTower Advisors, LLC: 50,676
2.05% of MiNK Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 898,731 shares in the last 24 months. This purchase volume represents approximately $808,858 in transactions.